Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya (pivmecillinam ...

ASU professor Glen D’Souza joined The Show to speak more about what he’s discovered about these bacteria: Not only will ...

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Micro-robots clear sinus infections without antibiotics Navigate sinuses using magnets and heat-activated action Showed ...

An immunocompromised woman’s cat stirred up a lot more trouble than usual (for a cat). In a recent case report, doctors ...

New research identifies key genes in "zombie" TB cells resistant to antibiotics, bringing new drugs one step closer.

Reserve antibiotics are used for infections caused by bacteria when conventional antibiotics are no longer effective. This is the case in MRSA, which causes roughly 20,000 infections per year in ...

Anaerobic bacteria were among the first life forms on Earth and existed at a time when there was no oxygen in the atmosphere.

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...